Form 4 for CLPT ClearPoint Neuro, Inc.
Accepted 2026-05-26 16:30:13 ET · period of report 2026-05-21 · accession 0001193125-26-239431 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-05-26 16:30 | 2026-05-21 | CLPT | Klein Matthew B. | Dir | S - Sale | $11.59 | -16.0K | 46.9K | -25% | -$185.4K |
| D | 2026-05-26 16:30 | 2026-05-21 | CLPT | Klein Matthew B. | Dir | A - Grant | $0.00 | +12.8K | 12.8K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-05-21 | S | D | 16,000 | $11.59 | 46,935 | D | — | — | (F1) Represents a weighted average sales price per share. The shares were sold at prices ranging from $11.57 to $11.65. The Reporting Person has provided to the issuer, and will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. |
| 2 | Derivative | Restricted Stock Units | 2026-05-21 | A | A | 12,820 | $0.00 | 12,820 | D | — · — to — | 12,820 Common Stock | (F2) Each restricted stock unit represents a contingent right to receive one share of CLPT common stock. (F3) The restricted stock units vest on the earlier of (i) the first anniversary of the grant date, or (ii) the day immediately preceding the Company's 2027 annual meeting of stockholders. (F3) The restricted stock units vest on the earlier of (i) the first anniversary of the grant date, or (ii) the day immediately preceding the Company's 2027 annual meeting of stockholders. |